STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Stat News • 10/14/2026
Summary
Lobbying groups for doctors and hospitals, along with trade groups, are actively working to influence how states regulate artificial intelligence in medicine. These efforts are taking place behind the scenes.
Advertisement
Lindy Score Breakdown (V4.2)
8h
Age
1
Sources
from cluster
1
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier99% (0.5^1/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds
Stat News • Today
STAT+: Doctors are giving generously to doctors running for office
Stat News • 1 day ago
STAT+: FTC demands Martin Shkreli divest his pharma stocks
Stat News • 1 day ago
STAT+: FDA adcomm members’ ties to industry under scrutiny
Stat News • Today
STAT+: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE
Stat News • 1 day ago
Opinion: How states can resist the potential Trump vaccine shortages
Stat News • Today
Opinion: STAT+: The epidemic of learned helplessness in physicians
Stat News • 1 day ago
STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more
Stat News • Today
STAT+: The startup chasing ‘general biological intelligence’
Stat News • Today